Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Atibuclimab for ARDS
Recruiting0 awardsPhase 2
Seattle, Washington
This trial will test a new treatment for patients with acute respiratory distress syndrome (ARDS) in the hospital. Patients will receive either a new medication called IC14 or a placebo through an IV. They will
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.